These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 7575688)
1. Monoclonal anticardiolipin autoantibodies established from the (New Zealand white x BXSB)F1 mouse model of antiphospholipid syndrome cross-react with oxidized low-density lipoprotein. Mizutani H; Kurata Y; Kosugi S; Shiraga M; Kashiwagi H; Tomiyama Y; Kanakura Y; Good RA; Matsuzawa Y Arthritis Rheum; 1995 Oct; 38(10):1382-8. PubMed ID: 7575688 [TBL] [Abstract][Full Text] [Related]
2. Anticardiolipin antibodies in NZW x BXSB F1 mice. A model of antiphospholipid syndrome. Hashimoto Y; Kawamura M; Ichikawa K; Suzuki T; Sumida T; Yoshida S; Matsuura E; Ikehara S; Koike T J Immunol; 1992 Aug; 149(3):1063-8. PubMed ID: 1634762 [TBL] [Abstract][Full Text] [Related]
4. Multigenic control of lupus-associated antiphospholipid syndrome in a model of (NZW x BXSB) F1 mice. Ida A; Hirose S; Hamano Y; Kodera S; Jiang Y; Abe M; Zhang D; Nishimura H; Shirai T Eur J Immunol; 1998 Sep; 28(9):2694-703. PubMed ID: 9754557 [TBL] [Abstract][Full Text] [Related]
5. Characterization of beta2-glycoprotein I-dependent and -independent "antiphospholipid" antibodies from lupus-prone NZW/BXSB F1 hybrid male mice. Thiagarajan P; Le A; Shapiro SS Am J Hematol; 1997 Oct; 56(2):86-92. PubMed ID: 9326349 [TBL] [Abstract][Full Text] [Related]
6. Overlap of the anti-cardiolipin and anti-nucleosome responses of the (NZW X BXSB)F1 mouse strain: a new pattern of cross-reactivity for lupus-related autoantibodies. Gilbert D; Lopez B; Parain J; Koutouzov S; Tron F Eur J Immunol; 2000 Nov; 30(11):3271-80. PubMed ID: 11093143 [TBL] [Abstract][Full Text] [Related]
7. Cross-reactivity of IgM and IgG anticardiolipin antibodies with oxidized-low density lipoproteins. Damoiseaux J; Jeyasekharan AD; Theunissen R; Tervaert JW Ann N Y Acad Sci; 2005 Jun; 1050():163-9. PubMed ID: 16014530 [TBL] [Abstract][Full Text] [Related]
8. Involvement of beta 2-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages. Hasunuma Y; Matsuura E; Makita Z; Katahira T; Nishi S; Koike T Clin Exp Immunol; 1997 Mar; 107(3):569-73. PubMed ID: 9067534 [TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of oxidized low-density lipoprotein antibody in antiphospholipid syndrome]. Hou YK; Cai QM; Liu XJ; Yun ZL; Li C; Zhang XW Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1117-1122. PubMed ID: 36533342 [TBL] [Abstract][Full Text] [Related]
10. Lack of cross-reaction between antibodies to beta2-glycoprotein-I and oxidized low-density lipoprotein in patients with antiphospholipid syndrome. Tinahones FJ; Cuadrado MJ; Khamashta MA; Mujic F; Gomez-Zumaquero JM; Collantes E; Hughes GR Br J Rheumatol; 1998 Jul; 37(7):746-9. PubMed ID: 9714350 [TBL] [Abstract][Full Text] [Related]
11. Association between anti-nucleophosmin and anti-cardiolipin antibodies in (NZW x BXSB)F1 mice and human systemic lupus erythematosus. Lartigue A; Drouot L; Jouen F; Charlionet R; Tron F; Gilbert D Arthritis Res Ther; 2005; 7(6):R1394-403. PubMed ID: 16277692 [TBL] [Abstract][Full Text] [Related]
13. IL-4Ralpha polymorphism in regulation of IL-4 synthesis by T cells: implication in susceptibility to a subset of murine lupus. Shiroiwa W; Tsukamoto K; Ohtsuji M; Lin Q; Ida A; Kodera S; Ohtsuji N; Nakamura K; Tsurui H; Kinoshita K; Nishimura H; Shirai T; Hirose S Int Immunol; 2007 Feb; 19(2):175-83. PubMed ID: 17189592 [TBL] [Abstract][Full Text] [Related]
14. Reduction of atherosclerosis in low-density lipoprotein receptor-deficient mice by passive administration of antiphospholipid antibody. Nicolo D; Goldman BI; Monestier M Arthritis Rheum; 2003 Oct; 48(10):2974-8. PubMed ID: 14558104 [TBL] [Abstract][Full Text] [Related]
15. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. Delgado Alves J; Kumar S; Isenberg DA Rheumatology (Oxford); 2003 Jul; 42(7):893-9. PubMed ID: 12730551 [TBL] [Abstract][Full Text] [Related]
16. Causal association between major histocompatibility complex and myocardial infarction in NZW x BXSB F1 mice. Kawano H; Kawano Y; Shirai T; Okada R Jpn Circ J; 1995 Feb; 59(2):98-102. PubMed ID: 7596028 [TBL] [Abstract][Full Text] [Related]
17. V gene analysis of anti-cardiolipin antibodies from (NZW x BXSB) F1 mice. Kita Y; Sumida T; Iwamoto I; Yoshida S; Koike T Immunology; 1994 Jul; 82(3):494-501. PubMed ID: 7959886 [TBL] [Abstract][Full Text] [Related]
18. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. Hörkkö S; Miller E; Dudl E; Reaven P; Curtiss LK; Zvaifler NJ; Terkeltaub R; Pierangeli SS; Branch DW; Palinski W; Witztum JL J Clin Invest; 1996 Aug; 98(3):815-25. PubMed ID: 8698874 [TBL] [Abstract][Full Text] [Related]
19. Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages. Kobayashi K; Tada K; Itabe H; Ueno T; Liu PH; Tsutsumi A; Kuwana M; Yasuda T; Shoenfeld Y; de Groot PG; Matsuura E Lupus; 2007; 16(12):929-38. PubMed ID: 18042586 [TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphism of murine tissue plasminogen activator associated with antiphospholipid syndrome. Shirai J; Ida A; Jiang Y; Sanokawa-Akakura R; Miura Y; Yan K; Hamano Y; Hirose S; Shirai T Genes Immun; 1999 Nov; 1(2):130-6. PubMed ID: 11196659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]